Literature DB >> 3294331

Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein.

T P Poirier1, M A Kehoe, E H Beachey.   

Abstract

Attenuated strains of Salmonella have been used effectively as vaccines against typhoid fever. We have investigated the use of such strains to deliver cloned antiphagocytic virulence determinants of unrelated bacteria. The aroA strain of S. typhimurium SL3261 was transformed with a low-copy plasmid vector pMK207, which contains the cloned gene spm5 encoding streptococcal M protein, the major virulence factor of these organisms. The transformed SL3261 expressed type 5 M protein in the cytoplasmic fraction, and when fed orally to BALB/c mice, evoked both serum and salivary IgA, IgG, and IgM antibodies directed against type 5 M protein. The orally immunized mice were completely protected against both intranasal and intraperitoneal challenge infections with virulent S. typhimurium SL1344 or M5 streptococci. These studies provide evidence that an attenuated strain of Salmonella can be used effectively as a general vaccine vehicle to deliver antiphagocytic virulence determinants of unrelated bacteria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294331      PMCID: PMC2188956          DOI: 10.1084/jem.168.1.25

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

2.  Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid.

Authors:  E M Lederberg; S N Cohen
Journal:  J Bacteriol       Date:  1974-09       Impact factor: 3.490

3.  Primary structure of protective antigens of type 24 streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

4.  Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification.

Authors:  L R Bullas; J I Ryu
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

5.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.

Authors:  G N Phillips; P F Flicker; C Cohen; B N Manjula; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

8.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

9.  Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen.

Authors:  I van de Rijn; J B Zabriskie; M McCarty
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein.

Authors:  V A Fischetti; K F Jones; B N Manjula; J R Scott
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin.

Authors:  S M Newton; M Kotb; T P Poirier; B A Stocker; E H Beachey
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

4.  Secretory immune responses to Mycoplasma pulmonis.

Authors:  M J Steffen; J L Ebersole
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

5.  Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers.

Authors:  J X Bao; J D Clements
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit.

Authors:  M P Sory; P Hermand; J P Vaerman; G R Cornelis
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Targeting vaccinia virus-expressed secretory beta subunit of human chorionic gonadotropin to the cell surface induces antibodies.

Authors:  J Srinivasan; O Singh; S Chakrabarti; G P Talwar
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice.

Authors:  J Thatte; S Rath; V Bal
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Natural killer cells mediate protection induced by a Salmonella aroA mutant.

Authors:  R Schafer; T K Eisenstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.